Literature DB >> 15686976

Dual-subtype FIV vaccine (Fel-O-Vax FIV) protection against a heterologous subtype B FIV isolate.

Ruiyu Pu1, James Coleman, James Coisman, Eiji Sato, Taishi Tanabe, Maki Arai, Janet K Yamamoto.   

Abstract

Vaccine trials were undertaken to determine whether the Fel-O-Vax FIV, a commercial dual-subtype (subtypes A and D) feline immunodeficiency virus (FIV) vaccine, is effective against a subtype B FIV isolate. Current results demonstrate the Fel-O-Vax FIV to be effective against a subtype B virus, a subtype reported to be the most common in the USA.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15686976     DOI： 10.1016/j.jfms.2004.08.005

Source DB:  PubMed          Journal:  J Feline Med Surg        ISSN： 1098-612X            Impact factor:   2.015


  17 in total

1.  Feline leukemia and feline immunodeficiency virus in Canada - A comment.

Authors:  Ed Doornenbal; Walt Ingwersen; Guillaume Cloutier
Journal:  Can Vet J       Date:  2012-01       Impact factor: 1.008

2.  AIDS vaccination studies with an ex vivo feline immunodeficiency virus model: analysis of the accessory ORF-A protein and DNA as protective immunogens.

Authors:  Mauro Pistello; Francesca Bonci; J Norman Flynn; Paola Mazzetti; Patrizia Isola; Elisa Zabogli; Valentina Camerini; Donatella Matteucci; Giulia Freer; Paolo Pelosi; Mauro Bendinelli
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

Review 3.  Advances in FIV vaccine technology.

Authors:  Elizabeth W Uhl; Marcus Martin; James K Coleman; Janet K Yamamoto
Journal:  Vet Immunol Immunopathol       Date:  2008-01-20       Impact factor: 2.046

4.  Evaluation of feline monocyte-derived dendritic cells loaded with internally inactivated virus as a vaccine against feline immunodeficiency virus.

Authors:  Giulia Freer; Donatella Matteucci; Paola Mazzetti; Francesca Tarabella; Valentina Catalucci; Enrica Ricci; Antonio Merico; Leonia Bozzacco; Mauro Pistello; Mauro Bendinelli
Journal:  Clin Vaccine Immunol       Date:  2008-01-23

5.  Feline immunodeficiency virus (FIV) vaccine efficacy and FIV neutralizing antibodies.

Authors:  James K Coleman; Ruiyu Pu; Marcus M Martin; Ezra N Noon-Song; Raphael Zwijnenberg; Janet K Yamamoto
Journal:  Vaccine       Date:  2013-06-22       Impact factor: 3.641

Review 6.  Feline immunodeficiency virus model for designing HIV/AIDS vaccines.

Authors:  Janet K Yamamoto; Missa P Sanou; Jeffrey R Abbott; James K Coleman
Journal:  Curr HIV Res       Date:  2010-01       Impact factor: 1.581

Review 7.  Feline leukemia virus and feline immunodeficiency virus in Canada: recommendations for testing and management.

Authors:  Susan Little; Dorothee Bienzle; Lisa Carioto; Hugh Chisholm; Elizabeth O'Brien; Margie Scherk
Journal:  Can Vet J       Date:  2011-08       Impact factor: 1.008

8.  Phylogenetic characterisation of naturally occurring feline immunodeficiency virus in the United Kingdom.

Authors:  A Samman; E L McMonagle; N Logan; B J Willett; R Biek; M J Hosie
Journal:  Vet Microbiol       Date:  2011-02-01       Impact factor: 3.293

Review 9.  Current progress in the development of a prophylactic vaccine for HIV-1.

Authors:  Lena J Gamble; Qiana L Matthews
Journal:  Drug Des Devel Ther       Date:  2010-12-22       Impact factor: 4.162

10.  Selective expansion of viral variants following experimental transmission of a reconstituted feline immunodeficiency virus quasispecies.

Authors:  Brian J Willett; Martin Kraase; Nicola Logan; Elizabeth McMonagle; Mariana Varela; Margaret J Hosie
Journal:  PLoS One       Date:  2013-01-23       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.